Medscape Medical NewsAll articles

TribusConnect

TribusMed Beheer BV • Radiology • 03/31/2025

510(k)IEC 62304 Class C§524B Cyber Device
FDA Summary PDF

Device Purpose

TribusConnect is a cloud-based medical image management and processing device designed to assist healthcare professionals in pre- and post-procedural planning for cardiac interventions. It leverages machine learning for advanced CT image analysis, validated through non-clinical testing and substantial equivalence to existing devices, demonstrating high accuracy in specialized functions like heart and LAA segmentation.

Summary

TribusMed Beheer BV has introduced TribusConnect, a cloud-based medical image management and processing device. Designed for healthcare professionals, this system allows remote access, review, manipulation, measurement, and visualization of computed tomography (CT) images stored in DICOM format. Its features include machine learning-based heart segmentation, simulated fluoroscopy, endo views, and measurements on MPR views. TribusConnect is intended for pre-procedural planning and post-procedural analysis of cardiac interventions in adult patients, serving as an adjunct tool and not for primary diagnostic use on mobile displays or as a primary image archive. The safety and effectiveness of TribusConnect were assessed through comprehensive non-clinical testing and comparison with established similar devices. The system was found to be substantially equivalent in its intended use, technological characteristics, functionality, and operating principles, with identified differences not introducing new risks. Performance testing verified compliance with design requirements, including accurate manual measurements within 5% of true values. Cybersecurity assessments confirmed robust security measures. Additionally, machine learning algorithms for heart segmentation and Left Atrial Appendage (LAA) localization were validated using a diverse dataset of 100 CT angiography volumes, demonstrating high accuracy and clinical usability, with no further clinical studies deemed necessary.

AI Regulatory Concerns

Powered byJev by TypeSafe AI

Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.

Keywords

TribusConnectcloud-basedmedical image managementCT imagesDICOMmachine learningheart segmentationcardiac interventionspre-procedural planningsubstantial equivalence

Device Metadata

Submission Number
K242166
Company
TribusMed Beheer BV
Panel
Radiology
Product Code
N/A
Data Type
N/A
Clinical Function
N/A
AI Function
N/A
AI Subclass
N/A

Relevant Clinical Questions

  • Q1. What specific types of cardiac interventions is TribusConnect optimized for pre- and post-procedural analysis, and what are its documented benefits for these procedures?; While TribusConnect is not for primary diagnostic use, how does it integrate with existing primary diagnostic systems and clinical workflows to enhance rather than complicate patient care?; What are the quantitative performance metrics (e.g., sensitivity, specificity, Dice similarity coefficient) for the machine learning-based heart segmentation and LAA localization beyond 'high accuracy'?; Given its cloud-based nature, what specific data encryption, access control, and disaster recovery protocols are implemented to ensure patient data privacy and system availability?; Were there any specific anatomical variations, image acquisition parameters, or patient populations within the 100 CT angiography volumes that presented challenges or limitations for the machine learning algorithms?

Risk Classification

ESL Analysis
FDA Device ClassII

FDA Class II via 510(k) pathway; IEC 62304 Class C (software safety classification); Qualifies as a cyber device under §524B (post-Dec 2023, networked)

Learn how Parasoft automates IEC 62304 compliance testing →

Cybersecurity Evidence

Powered by SBOMator™

Based on AI-generated device summaries, not the full FDA submission. Items not detected here may still be present in the complete submission package.

Cyber Score35/100
SBOM Evidence⚠ Not in summary - likely in full submission per §524B
Cyber Risk Assessment✓ Detected in Summary
Postmarket Plan⚠ Not in summary - likely in full submission per §524B
§524B ApplicableYes

Supply Chain BOM Evidence

Based on the CycloneDX / OWASP ECMA-424 xBOM ecosystem. Detection is from the AI-generated summary.

SBOMSoftware Bill of Materials
- Not detected
ML-BOMMachine Learning Bill of Materials(machine learning, algorithm, dataset)
✓ Detected
SaaSBOMSoftware-as-a-Service Bill of Materials(cloud, remote)
✓ Detected
HBOMHardware Bill of Materials
- Not detected
CBOMCryptography Bill of Materials(encryption)
✓ Detected
VDR/VEXVulnerability Disclosure Report / Vulnerability Exploitability eXchange
- Not detected
OBOMOperations Bill of Materials
- Not detected

Analysis:

• Analysis is based on the AI-generated device summary, not the full FDA submission package. Click "Analyze Full FDA PDF" below to scan the actual submission document.

• Evidence of ML-BOM, SaaSBOM, CBOM detected in AI-generated device summary.

• SBOM not mentioned in AI-generated device summary. Under §524B (effective Oct 2023), cyber devices must provide a SBOM.

• Postmarket cybersecurity monitoring plan not clearly documented in AI-generated device summary.

• Not detected in AI-generated device summary: SBOM, HBOM, VDR/VEX, OBOM. These may be present in the full FDA submission.

Preparing a similar submission?

ESL takes complete ownership of your software evidence work - SBOM & CVE remediation with SBOMator™, static analysis & unit testing with Parasoft, traceability, and full IEC 62304 lifecycle support.

Assess Your Readiness →Or contact ESL directly
TribusConnect - TribusMed Beheer BV | ESL FDA AI Device Intelligence